Logo
Logo
Johnson & Johnson Medical

Cidex OPA Ready To Use Solution

GIJ160 (3.78L)
Johnson & Johnson Medical code: 20391

Trustpilot

Out of Stock
Out of StockSorry this product is currently out of stock and is expected in the next two weeks

Retail Price
£99.66

Out of Stock
Out of StockSorry this product is currently out of stock and is expected in the next two weeks

Product Overview

Ortho-Phthalaldehyde Solution. Effective, fast acting. Achieves high-level disinfection in 5 minutes at 20°C. Fast-acting: fast turnaround of reprocessed instruments. Long-lasting efficacy - reusable for up to 14 days when monitored with Cidex OPA Test Strips. Easy-to-use: solution with low odour - requires no activation or mixing. Provides a broad-spectrum activity against bacteria, mycobacteria, viruses and fungi. Can be used to disinfect a wide range of medical instruments made of aluminium, brass, copper, stainless steel, plastics, elastomers and dental materials.

Features & Benefits:
  • Achieves high-levels of disinfection within 5 minutes at 20°C
  • Easy-to-use: solution with low odour - requires no activation or mixing.
  • Can be used to disinfect a broad range of instruments of all kinds of materials, including aluminium, brass, copper, stainless steel, plastics, elastomers and more.
Product Details:
  • 1 x 3.78L bottle of Cidex OPA Ready To Use Solution
FAQs:
What is the shelf life of Cidex OPA Ready to use solution?

This solution has a shelf life of 24 months, and an open bottle shelf life of 75 days.

Is the Cidex OPA Ready To Use Solution compatible with endoscopic instruments?

Yes, the near-neutral pH level of this solution ensures compatibility with endoscopic instruments.

Documentation

Reviews

Johnson & Johnson Medical

Cidex OPA Ready To Use Solution

GIJ160 (3.78L)
Johnson & Johnson Medical code: 20391

Trustpilot

Out of Stock
Out of StockSorry this product is currently out of stock and is expected in the next two weeks

Retail Price
£99.66

Out of Stock
Out of StockSorry this product is currently out of stock and is expected in the next two weeks